NervGen Pharma Corp. (NGENF) Technical Exchange News Jan. 09, 2026, 10:38 UTC 16 0 comments Grey symbol attribute type Security_Name was changed. Previous value: INDEPENDENCE PWR HLDGS A. New value: NERVGEN PHARMA CORP. Comment Full text
RenovoRx Inc. (RNXT) Technical Exchange News Jan. 09, 2026, 03:01 UTC 20 0 comments NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Propanc Biopharma, Inc. (PPCB) Technical Exchange News Jan. 09, 2026, 03:01 UTC 18 0 comments NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Inotiv Inc. (NOTV) Technical Exchange News Jan. 09, 2026, 03:01 UTC 20 0 comments NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Biofrontera Inc. (BFRI) Technical Exchange News Jan. 09, 2026, 03:01 UTC 18 0 comments NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
RenovoRx Inc. (RNXT) Technical Exchange News Jan. 08, 2026, 19:01 UTC 22 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Inotiv Inc. (NOTV) Technical Exchange News Jan. 08, 2026, 19:01 UTC 20 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Biofrontera Inc. (BFRI) Technical Exchange News Jan. 08, 2026, 19:00 UTC 19 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
ABOU RESIDENC-M (ABOU-M) Technical Exchange News Jan. 08, 2026, 18:51 UTC 26 0 comments ABOU RESIDENC-M (ABOU-M) was added to the list of traded instruments on TASE exchange Comment Full text
FibroGen Inc (FGEN) Technical Exchange News Jan. 08, 2026, 09:27 UTC 19 0 comments FibroGen Inc (FGEN) was removed from the list of traded instruments on NASDAQ exchange Comment Full text